Skip to Content

462 125 mg (Emend 125 mg)

Generic Name: aprepitant

Pill imprint 462 125 mg has been identified as Emend 125 mg.

Emend is used in the treatment of nausea/vomiting, chemotherapy induced; nausea/vomiting, postoperative and belongs to the drug class NK1 receptor antagonists. There is no proven risk in humans during pregnancy. Emend 125 mg is not a controlled substance under the Controlled Substance Act (CSA).

Emend 125 mg 462 125 mg
Emend 125 mg 462 125 mg
Discount Card Promo
Emend
Generic Name:
aprepitant
Imprint:
462 125 mg
Strength:
125 mg
Color:
Pink & White
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
NK1 receptor antagonists
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Manufacturer:
Merck & Company Inc.
National Drug Code (NDC):
00006-0462
Inactive Ingredients:
sucrose
microcrystalline cellulose
hydroxypropyl cellulose (type h)
sodium lauryl sulfate
gelatin
titanium dioxide
silicon dioxide
ferric oxide red
ferric oxide yellow

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide